Cero Therapeutics Holdings Inc (CERO) Live Share Price, Invest From India

Cero Therapeutics Holdings Inc Stock Performance

as on November 21, 2025 at 10:53 pm IST

Day's High
$0.06
Day's Price Range
$0.09
$0.06
50.00%
Upside
52 Week's Low
52 Week's High
$0.06
52-Week Price Range
$572
$0.06
-3.33%
Downside
953233.33%
Upside

Cero Therapeutics Holdings Inc share price movements today

Previous Close: $0.10
Open: $0.07
Volume: 7.2M
Day's Low - High: $0.06 - $0.09
52 Week Low - High: $0.06 - $572

Cero Therapeutics Holdings Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Cero Therapeutics Holdings Inc Stock Fundamentals & Key Indicators

Check Cero Therapeutics Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Cero Therapeutics Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cero Therapeutics Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cero Therapeutics Holdings Inc	NA	$-	NA	NA	0.00%
Insmed Incorporated	BUY	$42.6B	410.98%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$60.9B	257.49%	1439.88	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$107.9B	96.24%	29.59	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$74.5B	42.08%	16.84	32.13%

Cero Therapeutics Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	1	-
Gross Profit	-	-	0	0	0	0	0	-
Operating Income	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-2	-2	0	0	-2	-4	-5	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-439.10%	0.00%

Cero Therapeutics Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023
Total Revenue	-	-	-
Gross Profit	-	-	-1
Operating Income	-	-	-
EBITDA	-	-	-
Interest Expense	-	-	-
Depreciation	-	-	-
Income Before Tax	-	-	-
Income Tax Expense	-	-	-
Net Income	0	0	0
Net Profit Margin	0.00%	0.00%	0.00%

Cero Therapeutics Holdings Inc News & Key Events

Today's Timeline - 30 October
Thu, 07:05 PM
-
CERo Therapeutics stock plummets 80% after Nasdaq delisting notice due to failure to maintain required stockholders equity.

Insights on Cero Therapeutics Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 1009.8% return, outperforming this stock by 1108.9%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 184.3% return, outperforming this stock by 284.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CERO stock has moved down by -95.0%

About Cero Therapeutics Holdings Inc

CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body’s full immune repertoire to achieve optimized cancer therapy. This novel cellular immunotherapy platform is designed to redirect patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating what the Company refers to as Chimeric Engulfment Receptor T cells (CER-T). Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand. The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies.

Organisation	Cero Therapeutics Holdings Inc
E-voting on shares	Click here to vote

FAQs

What is Cero Therapeutics Holdings Inc share price today?

Cero Therapeutics Holdings Inc share price today is $0.06 as on November 21, 2025 at 10:53 pm IST. Cero Therapeutics Holdings Inc share today touched a day high of $0.09 and a low of $0.06.

What is the 52 week high and 52 week low for Cero Therapeutics Holdings Inc share?

Cero Therapeutics Holdings Inc share touched a 52 week high of $572 on November 21, 2024 and a 52 week low of $0.06 on October 31, 2025. Cero Therapeutics Holdings Inc stock price today i.e. November 21, 2025 at 10:53 pm IST is trending at $0.06,which is 99.99% down from its 52 week high and -3.23% up from its 52 week low.

How to invest in Cero Therapeutics Holdings Inc Stock (CERO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cero Therapeutics Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cero Therapeutics Holdings Inc Shares that will get you 25.0000 shares as per Cero Therapeutics Holdings Inc share price of $0.06 per share as on November 21, 2025 at 10:53 pm IST.

What is the minimum amount required to buy Cero Therapeutics Holdings Inc Stock (CERO) from India?

Indian investors can start investing in Cero Therapeutics Holdings Inc (CERO) shares with as little as ₹89.642 or $1 (as of November 21, 2025 at 11:23 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹896.42 in Cero Therapeutics Holdings Inc stock (as per the Rupee-Dollar exchange rate as on November 21, 2025 at 11:23 pm IST). Based on Cero Therapeutics Holdings Inc share’s latest price of $0.06 as on November 21, 2025 at 10:53 pm IST, you will get 166.6667 shares of Cero Therapeutics Holdings Inc. Learn more about fractional shares .

Cero Therapeutics Holdings Inc Share Price